Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis

por Martínez-González, Loreto, Gonzalo-Consuegra, Claudia, Gómez-Almería, Marta, Porras, Gracia, de Lago, Eva, Martín-Requero, Ángeles, Martínez, Ana
Publicado 2021

Inactivation of the CB(2) receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis

por Rodríguez‐Cueto, Carmen, Gómez‐Almería, Marta, García Toscano, Laura, Romero, Julián, Hillard, Cecilia J., de Lago, Eva, Fernández‐Ruiz, Javier
Publicado 2021

BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis

por Gómez-Almería, Marta, Burgaz, Sonia, Costas-Insua, Carlos, Rodríguez-Cueto, Carmen, Santos-García, Irene, Rodríguez-Crespo, Ignacio, García, Concepción, Guzmán, Manuel, de Lago, Eva, Fernández-Ruiz, Javier
Publicado 2021

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis

por Burgaz, Sonia, García, Concepción, Gonzalo-Consuegra, Claudia, Gómez-Almería, Marta, Ruiz-Pino, Francisco, Unciti, Juan Diego, Gómez-Cañas, María, Alcalde, Juan, Morales, Paula, Jagerovic, Nadine, Rodríguez-Cueto, Carmen, de Lago, Eva, Muñoz, Eduardo, Fernández-Ruiz, Javier
Publicado 2021